FDA 483 - Vitalant - May 02, 2022

An FDA inspection of Vitalant's Donor Collection Center in Yuba City, CA, revealed two observations related to procedural non-compliance. The firm failed to consistently follow manufacturer instructions for arm preparation applicators and did not adhere to its own written standard operating procedures for blood collection. These issues indicate a lack of strict adherence to established protocols during donor blood collection.